
Over the past several years, the CELDi Biopharmaceutical Operations Initiative at UC
Berkeley has worked with a variety of biopharmaceutical firms to optimize production
planning and supply chain management. Production and supply chain operations in the
biopharmaceutical industry feature a variety of characteristics that make production
and inventory planning challenging. For instance,
• Bulk production has significant economies of scale, and capacity is shared, leading
to campaign-style production.
• Bulk production is either in batches, with significant levels of random yield, or
semi-continuous (known as a perfusion process), with random production rates
(although rates are known soon after production starts).
• There is significant region-specific differentiation between bulk production and
finished goods production (filling/finishing/labeling).
• There is an expiration period for bulk drugs, and a new, non-cumulative expira-
tion period for finished drugs.
• In some cases, bulk production batches must be entirely differentiated (that is,
processed into finished goods for specific markets), even if it would be more
efficient to partially differentiate them.
• Quality analysis can take significantly more time than production, with a very
high variability in the required amount of time.
• In many cases, some but not all production steps are outsourced, so:
– Utilization of this outsourced capacity must be “scheduled” in advance
– Even a large biopharmaceutical firm may be a small customer of the out-
sourcer.
– There can be great uncertainty in the time until outsourced jobs are returned
from the contract manufacturer, even though production itself is quite quick
• Disruptions can have tremendous negative impact, so detailed knowledge of the
tradeoff between inventory cost, covered disruptions, and customer service are
very useful for decision-making.
Solving an integrated planning/operations model with these characteristics is obvi-
ously quite challenging. The overall strategy of the CELDi Biopharmaceutical Opera-
tions Initiative is, therefore, two-fold: first, analyze simple, stylized models with some
of these characteristics to better understand policies for these models. Second, use
optimization and simulation-optimization techniques to optimize parameter settings in
more complex systems.
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link
Also see:


